Hackensack Meridian Health

This study looked at whether the blood pressure drug telmisartan could prevent a serious immune reaction called graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. About 32 participants were planned, but the study was stopped early. The …

This study looked at two different drug combinations given before a stem cell transplant for people with certain blood cancers (like leukemia). The goal was to see which combination better prevented the cancer from coming back within a year. The study was stopped early after enro…

This study tested a mix of drugs (cyclophosphamide, sirolimus, and azacitidine) to help patients whose graft-versus-host disease (GVHD) did not improve with steroids. GVHD is a serious condition where donor immune cells attack the patient's body after a stem cell transplant. The …

This study looked at whether giving two immune-boosting drugs (nivolumab and ipilimumab) after a stem cell transplant could help prevent cancer from coming back in people with high-risk multiple myeloma or lymphoma. The trial enrolled 46 adults aged 18 to 80. The main goal was to…

This study tested a culturally tailored diabetes education program to help adult Hispanic men (ages 18-64) with type 2 diabetes improve their self-care habits, like healthy eating, exercise, and taking medication as prescribed. The program was designed to be community-based and l…

This study compared standard paper-based diabetes education to tablet-based learning for people newly diagnosed with type 1 diabetes. About 28 participants were enrolled to see if the tablet approach improved knowledge and blood sugar control. The study was terminated early, so r…